Showing results (41-50 of 170) with videos related to
Sort By:
Pageof 17
Drug Safety|December 22, 1999
Cardiac effects of ebastine and other antihistamines in humansA J Moss, J MorganrothJournal of Clinical Pharmacology|February 1, 1995
Effects of food on the bioequivalence of different verapamil sustained-release formulationsS A Waldman, J MorganrothThe American Journal of Cardiology|August 1, 1986
Effectiveness of low-dose nadolol for ventricular arrhythmiasJ Morganroth, K L DuchinThe American Journal of Cardiology|January 15, 1989
Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine)J Morganroth, C M PrattAnnals of the New York Academy of Sciences|January 1, 1977
The athlete's heart syndrome: a new perspectiveJ Morganroth, B J MaronCirculation|November 1, 1991
Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysisJ Morganroth, J E GoinCirculation|November 1, 1977
New criteria to enhance the predictability of coronary artery disease by exercise testing in asymptomatic subjectsE C Lozner, J MorganrothThe American Journal of Cardiology|August 1, 1986
Implications of abnormal right ventricular thallium uptake in acute myocardial infarctionP F Nestico, A H Hakki, J Felsher, et al.The American Journal of Cardiology|October 1, 1985
Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmiasJ Morganroth, L N HorowitzThe American Journal of Cardiology|February 27, 1984
Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogramJ Morganroth, L N HorowitzPageof 17